Evidence map›Paper›PMID 29722436›Full record

ArticleBritish journal of pharmacology2018

Cigarette smoke up-regulates PDE3 and PDE4 to decrease cAMP in airway cells.

Haoxiao Zuo, Bing Han, Wilfred J Poppinga, Lennard Ringnalda, Loes E M Kistemaker, Andrew J Halayko, Reinoud Gosens, Viacheslav O Nikolaev, Martina Schmidt

Open access · hybridAbstract read
In one paragraph

Article in British journal of pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Nicotine Impairs Smooth Muscle cAMP Signaling and Vascular Reactivity.Microcirculation (New York, N.Y. : 1994) · 2024
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Haoxiao ZuoDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-5810-3799
Bing HanDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.
Wilfred J PoppingaDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-2711-2411
Lennard RingnaldaDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.
Loes E M KistemakerDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-7742-8748
Andrew J HalaykoDepartment of Physiology and Pathophysiology, University of Manitoba, Winnipeg, Canada.ORCID 0000-0002-7865-4552
Reinoud GosensDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-5595-152X
Viacheslav O NikolaevInstitute of Experimental Cardiovascular Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-7529-5179
Martina SchmidtDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.ORCID 0000-0003-3075-0630
University Medical Center Groningen · NLUniversität Hamburg · DEUniversity of Groningen · NLUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposecAMP is a central second messenger that broadly regulates cell function and can underpin pathophysiology. In chronic obstructive pulmonary disease, a lung disease primarily provoked by cigarette smoke (CS), the activation of cAMP-dependent pathways, via inhibition of hydrolyzing PDEs, is a major therapeutic strategy. Mechanisms that disrupt cAMP signalling in airway cells, in particular regulation of endogenous PDEs, are poorly understood. EXPERIMENTAL APPROACH: We used a novel Förster resonance energy transfer (FRET) based cAMP biosensor in mice in vivo, ex vivo precision cut lung slices (PCLS) and in human cell models, in vitro, to track the effects of CS exposure. KEY

resultsUnder fenoterol stimulation, FRET responses to cilostamide were significantly increased in in vivo, ex vivo PCLS exposed to CS and in human airway smooth muscle cells exposed to CS extract. FRET signals to rolipram were only increased in the in vivo CS model. Under basal conditions, FRET responses to cilostamide and rolipram were significantly increased in in vivo, ex vivo PCLS exposed to CS. Elevated FRET signals to rolipram correlated with a protein up-regulation of PDE4 subtypes. In ex vivo PCLS exposed to CS extract, rolipram reversed down-regulation of ciliary beating frequency, whereas only cilostamide significantly increased airway relaxation of methacholine pre-contracted airways. CONCLUSION AND IMPLICATIONS: Exposure to CS, in vitro or in vivo, up-regulated expression and activity of both PDE3 and PDE4, which affected real-time cAMP dynamics. These mechanisms determine the availability of cAMP and can contribute to CS-induced pulmonary pathophysiology.

Indexed as

SmokeTobacco ProductsAnimalsBiosensing TechniquesCell LineCyclic AMPCyclic Nucleotide Phosphodiesterases, Type 3Cyclic Nucleotide Phosphodiesterases, Type 4Epithelial CellsFluorescence Resonance Energy TransferHumansMice, TransgenicMyocytes, Smooth MusclePhosphodiesterase 3 InhibitorsPhosphodiesterase 4 InhibitorsQuinolonescilostamideCyclic AMPCyclic Nucleotide Phosphodiesterases, Type 3Cyclic Nucleotide Phosphodiesterases, Type 4Phosphodiesterase 3 InhibitorsPhosphodiesterase 4 InhibitorsQuinolonesRolipramSmoke

Identifiers

PMID29722436
PMCPMC6016635
OpenAlexW2803024782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.